HK1242917A1 - 腫瘤抑制基因的雜合修飾和1型神經纖維瘤病的豬模型 - Google Patents
腫瘤抑制基因的雜合修飾和1型神經纖維瘤病的豬模型Info
- Publication number
- HK1242917A1 HK1242917A1 HK18102608.0A HK18102608A HK1242917A1 HK 1242917 A1 HK1242917 A1 HK 1242917A1 HK 18102608 A HK18102608 A HK 18102608A HK 1242917 A1 HK1242917 A1 HK 1242917A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tumor suppressor
- suppressor genes
- neurofibromatosis type
- swine model
- heterozygous
- Prior art date
Links
- 208000003019 Neurofibromatosis 1 Diseases 0.000 title 1
- 208000024834 Neurofibromatosis type 1 Diseases 0.000 title 1
- 241000282898 Sus scrofa Species 0.000 title 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 title 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
- A01K2217/077—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/108—Swine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Environmental Sciences (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462078857P | 2014-11-12 | 2014-11-12 | |
PCT/US2015/060101 WO2016077429A1 (en) | 2014-11-12 | 2015-11-11 | Heterozygous modifications of tumor suppressor genes and swine model of neurofibromatosis type 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1242917A1 true HK1242917A1 (zh) | 2018-07-06 |
Family
ID=54754762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18102608.0A HK1242917A1 (zh) | 2014-11-12 | 2018-02-23 | 腫瘤抑制基因的雜合修飾和1型神經纖維瘤病的豬模型 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20160160238A1 (zh) |
EP (1) | EP3218393A1 (zh) |
JP (1) | JP2017533716A (zh) |
CN (1) | CN107105634A (zh) |
AU (1) | AU2015346422A1 (zh) |
CA (1) | CA2967027A1 (zh) |
HK (1) | HK1242917A1 (zh) |
WO (1) | WO2016077429A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200029538A1 (en) * | 2016-11-28 | 2020-01-30 | Osaka University | Genome editing method |
EP3420811A1 (en) * | 2017-06-29 | 2019-01-02 | Paris Sciences et Lettres - Quartier Latin | Non-human model for neurofibromatosis type 1 |
US11859213B2 (en) | 2019-05-16 | 2024-01-02 | Regents Of The University Of Minnesota | Development of superior chimerism by hiPSC engineering and embryo aggregation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
AU6218899A (en) | 1998-10-12 | 2000-05-01 | Geron Bio-Med Limited | Porcine oocytes with improved developmental competence |
EP1255858A2 (en) * | 1999-10-18 | 2002-11-13 | Universiteit Gent | Improved mutation analysis of the nf1 gene |
WO2001030965A2 (en) | 1999-10-28 | 2001-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of in vivo gene transfer using a sleeping beauty transposon system |
CN100575485C (zh) | 2002-01-23 | 2009-12-30 | 犹他大学研究基金会 | 使用锌指核酸酶的定向染色体诱变 |
US7985739B2 (en) | 2003-06-04 | 2011-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced sleeping beauty transposon system and methods for using the same |
EP1913149A4 (en) * | 2005-07-26 | 2009-08-05 | Sangamo Biosciences Inc | TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES |
US20110023159A1 (en) | 2008-12-04 | 2011-01-27 | Sigma-Aldrich Co. | Ovine genome editing with zinc finger nucleases |
KR20100080068A (ko) | 2008-12-31 | 2010-07-08 | 주식회사 툴젠 | 신규한 징크 핑거 뉴클레아제 및 이의 용도 |
WO2010124200A2 (en) * | 2009-04-23 | 2010-10-28 | Transposagen Biopharmaceuticals, Inc. | Genetically modified rat models for cancer |
US20120192298A1 (en) | 2009-07-24 | 2012-07-26 | Sigma Aldrich Co. Llc | Method for genome editing |
NZ598457A (en) | 2009-08-03 | 2014-06-27 | Recombinetics Inc | Methods and compositions for targeted gene modification |
EP2510096B2 (en) | 2009-12-10 | 2018-02-07 | Regents of the University of Minnesota | Tal effector-mediated dna modification |
EP3450563A1 (en) * | 2011-02-25 | 2019-03-06 | Recombinetics, Inc. | Genetically modified animals and methods for making the same |
MX351043B (es) * | 2011-04-27 | 2017-09-29 | Amyris Inc | Metodos para modificacion genomica. |
US10172333B2 (en) * | 2013-03-15 | 2019-01-08 | Exemplar Genetics, Llc | Animal models of cancer |
-
2015
- 2015-11-11 CN CN201580071457.4A patent/CN107105634A/zh active Pending
- 2015-11-11 JP JP2017525598A patent/JP2017533716A/ja active Pending
- 2015-11-11 WO PCT/US2015/060101 patent/WO2016077429A1/en active Application Filing
- 2015-11-11 CA CA2967027A patent/CA2967027A1/en not_active Abandoned
- 2015-11-11 AU AU2015346422A patent/AU2015346422A1/en not_active Abandoned
- 2015-11-11 US US14/938,295 patent/US20160160238A1/en not_active Abandoned
- 2015-11-11 EP EP15802258.2A patent/EP3218393A1/en not_active Withdrawn
-
2018
- 2018-02-23 HK HK18102608.0A patent/HK1242917A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3218393A1 (en) | 2017-09-20 |
JP2017533716A (ja) | 2017-11-16 |
US20160160238A1 (en) | 2016-06-09 |
AU2015346422A1 (en) | 2017-05-25 |
WO2016077429A1 (en) | 2016-05-19 |
CA2967027A1 (en) | 2016-05-19 |
CN107105634A (zh) | 2017-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL258931A (en) | Medicinal compounds and methods | |
HK1232141A1 (zh) | 用於治療亨廷頓病的方法和組合物 | |
AP2016009479A0 (en) | Transgenic maize event mon 87419 and methods of use thereof | |
GB2561352B (en) | Animal models and therapeutic molecules | |
ZA201606349B (en) | Radiotherapy board and couch | |
PL3096765T3 (pl) | Leczenie zaburzeń metabolicznych u zwierząt psowatych | |
PL4000362T3 (pl) | Kopiująca ukształtowanie terenu belka narzędziowa maszyny | |
EP3362578A4 (en) | METHODS OF GENOMIC EVALUATION OF LIVESTOCK | |
HUE062087T2 (hu) | Peszticid gének és eljárások a felhasználásra | |
IL250289B (en) | Antibodies against angiopoietin-like 4 and methods of use | |
EP3188600A4 (en) | Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesis | |
SG11201706054QA (en) | Enterovirus 71 animal model | |
HK1242917A1 (zh) | 腫瘤抑制基因的雜合修飾和1型神經纖維瘤病的豬模型 | |
GB201511207D0 (en) | Isolated organ evaluation and treatment | |
PL3136845T3 (pl) | Ściółka dla drobiu | |
EP3250037A4 (en) | Compositions and methods for creating pancreatic cancer animal model | |
HK1244782A1 (zh) | 用於治療疾病和病癥的組合物和方法 | |
HK1255346A1 (zh) | 前列腺癌的嚙齒動物模型 | |
GB201704983D0 (en) | Animal model | |
IL253435A0 (en) | Structures and methods for placement | |
GB201404459D0 (en) | Animal hydrating composition with luring effect | |
ZA201901285B (en) | Methods and compositions for modifying the behavior of animals | |
GB201510157D0 (en) | Improved animal model | |
IL250244B (en) | Prevention and treatment of inflammatory skin diseases | |
GB201510241D0 (en) | Animal model |